Medicare Enrolled

Dr. James Lemert, M.D.

Urology Physician · Amarillo, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
1900 MEDI PARK DR, Amarillo, TX 79106
8063559447
In practice since 2010 (16 years)
NPI: 1851617310 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lemert from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lemert? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lemert

Dr. James Lemert is an urology physician in Amarillo, TX, with 16 years in practice. Based on federal Medicare data, Dr. Lemert performed 24,100 Medicare services across 3,387 unique beneficiaries.

Between the years covered by Open Payments, Dr. Lemert received a total of $5,648 from 33 pharmaceutical and/or device companies across 246 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lemert is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice▲ Top 3% volume in TX$ $5,648 industry payments

Medicare Practice Summary

Medicare Utilization ↗
24,100
Medicare services
Top 3% in TX for urology physician
3,387
Unique beneficiaries
$18
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,506 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Denosumab injection (Prolia/Xgeva)10,260$18$45
Contrast dye for imaging (iodine-based)9,202$0$2
Urinalysis with microscopic exam907$3$21
Office visit, established patient (30-39 min)851$85$259
PSA test (prostate cancer screening)527$18$70
Bladder ultrasound after voiding497$7$50
Leuprolide acetate (for depot suspension), 7.5 mg492$134$1,000
Diagnostic exam of bladder and urethra using an endoscope159$58$591
Psa (prostate specific antigen) measurement, free129$18$70
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle84$24$75
Blood creatinine level83$5$20
New patient office visit (45-59 min)71$109$397
Ct scan of abdomen and pelvis before and after contrast64$190$650
Ultrasound scan of pelvic region through rectum61$23$275
X-ray of abdomen, 1 view57$20$66
Drug injection, under skin or into muscle57$11$50
Ct scan of abdomen and pelvis without contrast53$72$375
Biopsy of prostate gland52$86$530
Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method48$141$1,075
Imaging of urinary tract following injection of a contrast agent44$19$103
Complete blood count (CBC) with differential39$8$25
Office visit, established patient (20-29 min)35$59$175
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle34$50$275
Insertion of stent in ureter using an endoscope31$91$345
Hospital follow-up visit, low complexity28$39$95
Complex measurement of pressure of urine flow in bladder with voiding pressure studies25$173$740
Crushing of stone of ureter with insertion of stent using an endoscope25$306$1,050
Complete ultrasound scan behind abdominal cavity25$71$276
Insertion of device into abdomen with pressure and urine flow rate study24$102$350
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional23$15$48
Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope21$111$590
CT scan of chest, without contrast20$34$375
Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings19$24$400
Ct scan of abdomen before and after contrast16$138$650
Electronic assessment of bladder emptying14$3$200
Initial hospital admission, high complexity12$136$475
Insertion of tube into ureter using an endoscope through bladder area11$102$700
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.3% high complexity
85.1% medium
14.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$5,648
Total received (2018-2024)
Avg $807/year across 7 years
Top 35% in TX for urology physician
33
Companies
246
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,434 (96.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$214 (3.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$451
2023
$731
2022
$677
2021
$475
2020
$1,656
2019
$886
2018
$773

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
CIPLA USA INC.
$1,302
Astellas Pharma US Inc
$1,300
Dendreon Pharmaceuticals LLC
$440
Janssen Biotech, Inc.
$396
PFIZER INC.
$351
ABBVIE INC.
$332
Myriad Genetic Laboratories, Inc.
$221
Merck Sharp & Dohme LLC
$180
Amgen Inc.
$132
Sumitomo Pharma America, Inc.
$122
UroGen Pharma, Inc.
$119
AbbVie Inc.
$108
UROVANT SCIENCES INC
$78
Boston Scientific Corporation
$72
TOLMAR Pharmaceuticals, Inc.
$66
Janssen Products, LP
$60
Sun Pharmaceutical Industries Inc.
$40
Coloplast Corp
$35
Novartis Pharmaceuticals Corporation
$30
AbbVie, Inc.
$27
Laborie Medical Technologies Corp.
$27
NeoTract Inc.
$26
Allergan, Inc.
$25
Allergan Inc.
$23
Olympus America Inc.
$21
GENZYME CORPORATION
$18
SANOFI-AVENTIS U.S. LLC
$15
BAUDAX BIO INC.
$15
Bayer HealthCare Pharmaceuticals Inc.
$15
Intuitive Surgical, Inc.
$15
Tolmar, Inc.
$14
Antares Pharma, Inc.
$14
Endo Pharmaceuticals Inc.
$11
Top 3 companies account for 53.9% of total payments
Associated products mentioned in payments ›
ANJESO · BOTOX · BRACANALYSIS CDX · Da Vinci Surgical System · ELIGARD · ERLEADA · Erleada · GEMTESA · GENERAL THERAPIES · JELMYTO · JEVTANA · KEYTRUDA · LITHOVUE · LUPRON DEPOT · LYNPARZA · Lupron · Lupron Depot · MYRBETRIQ · MYRISK · Myrbetriq · NOCDURNA · Nubeqa · ORGOVYX · PLUVICTO · PROLARIS · PROVENGE · Prolia · REZUM · Soltive · SpaceOAR VUE System - 10mL · SpeediCath · TALZENNA · TOVIAZ · UroLift · VESICARE · XGEVA · XIAFLEX · XTANDI · Xtandi · YONSA · ZEMDRI (PLAZOMICIN) · ZYTIGA · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $23 per 100 Medicare services performed
Looking for a urology physician in Amarillo?
Compare urology physicians in the Amarillo area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology Physicians within 10 mi
10
Per 100K population
8.6
County median income
$50,448
Nearest hospital
NORTHWEST TEXAS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Lemert is a mixed practice specialist, with above-average Medicare volume (top 3% in TX), and low-engagement industry engagement, with 16 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Lemert experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Lemert performed 10,260 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lemert receive payments from pharmaceutical companies?
Yes. Dr. Lemert received a total of $5,648 from 33 companies across 246 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lemert's costs compare to other urology physicians in Amarillo?
Dr. Lemert's average Medicare payment per service is $18. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lemert) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →